
Genetic Twist Could Help Some Prediabetes Patients Benefit from Vitamin D
New analysis of the D2d trial suggests that high-dose vitamin D (4,000 IU/day) may lower progression to type 2 diabetes by about 19% in people with prediabetes who carry certain ApaI variations of the vitamin D receptor gene. This is not universal; prior trials showed mixed results and lifestyle changes—diet and exercise—remain the main prevention strategy. Genetic testing isn’t standard yet, but baseline vitamin D status and follow-up blood levels can guide decisions. Achieving higher blood 25-hydroxyvitamin D levels (around 40 ng/mL) may require doses above 4,000 IU/day for some individuals. Supplements are not a cure; discuss with a clinician, especially during pregnancy, nursing, or for children.













